Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes
Xiaoyu Wang,Guangbing Li,Changfa Guo,Jiayao Zhang,Junjie Kong,Jingyi He,Feiyu Li,Yong Liu,Yang Yang,Ziwen Lu,Jun Liu
DOI: https://doi.org/10.2147/DMSO.S321246
2021-10-02
Abstract:Xiaoyu Wang, 1 Guangbing Li, 1, 2 Changfa Guo, 3 Jiayao Zhang, 1 Junjie Kong, 1, 2 Jingyi He, 1, 2 Feiyu Li, 1 Yong Liu, 1 Yang Yang, 1 Ziwen Lu, 1 Jun Liu 1, 2 1 Department of Hepatobiliary Surgery and Center of Organ Transplantation, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China; 2 Department of Hepatobiliary Surgery and Center of Organ Transplantation, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China; 3 Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Cheeloo College of Medicine, Jinan, Shandong, People's Republic of China Correspondence: Jun Liu Department of Hepatobiliary Surgery and Center of Organ Transplantation, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, People's Republic of China Email Background: The AMP-activated protein kinase alpha (AMPKα) pathway has widely been considered a key factor in energy metabolism. Ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl] acetate (TMPA) is a novel AMPK agonist, which influences the stability of Nuclear Receptor Subfamily 4, Group A, Member 1 (Nur77)-serine-threonine kinase 11 (LKB1) in the nucleus. A recent study has determined that TMPA can ameliorate the reduction of insulin resistance in type II db/db mice. However, the role of TMPA in hepatocyte lipid metabolism has not been elucidated. Objective: To investigate whether TMPA could ameliorate liver lipid accumulation under the stimulation of free fatty acids (FFAs) in vitro. Methods: We evaluated differences of Nur77 and AMPK pathway in mice fed a high-fat diet and those fed a normal diet. In vitro, TMPA was added to HepG2 cells and primary hepatocytes before FFAs stimulation. Oil red O staining, Nile red staining were used to evaluate lipid deposition. Western blot and immunofluorescence were used to quantify related proteins. Results: Nur77, AMPKα, LKB1, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), acetyl-CoA carboxylase phosphorylation (p-ACC), and carnitine palmitoyltransferase 1 (CPT1A) showed significant differences in vivo. Under the intervention of TMPA, HepG2 cells and primary hepatocytes showed considerable amelioration of lipid deposition and improved the expression of phosphorylated (p)-AMPKα (p-AMPKα), p-LKB1, p-ACC, and CPT1A. Furthermore, Western blotting and immunofluorescence studies indicated that LKB1 dramatically increased expression in the cytoplasm but decreased in the nucleus. Further, AMPKα phosphorylation (p-AMPKα) also showed a higher expression in cytoplasm instead of the nucleus. Conclusion: TMPA ameliorated lipid accumulation by influencing the stability of Nur77-LKB1 in vitro. Keywords: ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl] acetate, Nur77, AMPK pathway, HepG2 cells, primary hepatocytes Metabolic associated fatty liver disease (MAFLD) is an umbrella term for a comprehensive range of liver diseases, including nonalcoholic fatty liver disease (NAFLD), and the more severe nonalcoholic steatohepatitis (NASH). 1 MAFLD is the most common cause of chronic liver disease in the world, and increasing evidence shows that MAFLD is a multi-systemic disease, affecting extra-hepatic organs and regulatory pathways. Many factors can generate the occurrence and progression of this disease, such as type 2 diabetes mellitus (T2DM), cardiovascular (CVD), cardiac diseases, and chronic kidney disease (CKD). 2 As MAFLD progresses, many patients will progress to liver cirrhosis and end-stage hepatocellular carcinoma. The increase in prevalence of this chronic disease has caused a growing economic burden and reduced the quality of life for many elderly individuals. 3 Nuclear Receptor Subfamily 4, Group A, Member 1 (Nur77, also called TR3, NGFIB, and NR4A1), is an orphan member of the nuclear receptor superfamily and plays a critical role in apoptosis, fibrosis, glucose metabolism, inflammation, lipid metabolism, and in the regeneration and injury of cells. 4–9 More recently, Nur77 has been shown to be involved in glucose and lipid metabolism, 10,11 especially through the serine-threonine kinase 11/AMP-activated protein kinase (LKB1/AMPK) pathway. The LKB1/AMPK axis is considered a crucial metabolic sensor in cellular homeostasis especially for glucose and lipid metabolism. 12,13 The AMPK pathway is altered following exposure to a mixture of free fatty acids (FFAs) in HepG2 cells. 14 During lipid metabo -Abstract Truncated-
endocrinology & metabolism